(Q44605622)

4 December 2017

Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database (English)

1 reference

Hormone Replacement Therapy

4 December 2017

1 reference

inferred from title

author name string

Alexandra Papaioannou

1

1 reference

4 December 2017

George Ioannidis

2

1 reference

4 December 2017

Nicole Ferko

5

1 reference

4 December 2017

Mark Puglia

6

1 reference

4 December 2017

Jacques Brown

7

1 reference

4 December 2017

Alan Tenenhouse

8

1 reference

4 December 2017

Pauline Boulos

10

1 reference

4 December 2017

Robert Josse

12

1 reference

4 December 2017

Annie Petrie

14

1 reference

4 December 2017

Jonathan D. Adachi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523610

17 March 2024

Rolf J. Sebaldt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523610

17 March 2024

Wojciech P. Olszynski

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523610

17 March 2024

David A. Hanley

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523610

17 March 2024

Timothy M. Murray

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523610

17 March 2024

Charlie H. Goldsmith

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523610

17 March 2024

language of work or name

English

0 references

publication date

11 September 2003

1 reference

full work available at URL

4 December 2017

http://link.springer.com/content/pdf/10.1007/s00198-003-1431-2.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00198-003-1431-2

http://link.springer.com/article/10.1007/s00198-003-1431-2/fulltext.html

17 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00198-003-1431-2

http://link.springer.com/content/pdf/10.1007/s00198-003-1431-2

17 March 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00198-003-1431-2

Osteoporosis International

17 March 2024

published in

1 reference

4 December 2017

14

1 reference

4 December 2017

10

1 reference

4 December 2017

808-813

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-003-1431-2

4 December 2017

0 references

cites work

Compliance with hormone therapy

1 reference

12 December 2020

Postmenopausal hormonal support: discontinuation of raloxifene versus estrogen

1 reference

12 December 2020

Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre

1 reference

12 December 2020

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

12 December 2020

Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation

1 reference

12 December 2020

Editorial: Single daily dose of antidepressants

1 reference

12 December 2020

Beyond "compliance" is "adherence". Improving the prospect of diabetes care

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

1 reference

12 December 2020

Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis

1 reference

12 December 2020

Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy

1 reference

12 December 2020

A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.

1 reference

12 December 2020

Drug Defaulting in a General Practice

1 reference

12 December 2020

Osteoporosis management: physicians' recommendations and womens' compliance following osteoporosis testing

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Improving adherence to hormone replacement therapy with effective patient-physician communication

1 reference

12 December 2020

Effect of age on reasons for initiation and discontinuation of hormone replacement therapy

1 reference

12 December 2020

Compliance considerations with hormone replacement therapy

1 reference

12 December 2020

The impact of different HRT regimens on compliance.

1 reference

12 December 2020

Patients' Compliance With Health Regimens

1 reference

12 December 2020

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Improving compliance with hormonal replacement therapy in primary osteoporosis prevention

1 reference

12 December 2020

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

1 reference

12 December 2020

Identifiers

DOI

1 reference

4 December 2017

1 reference